BioNTech SE (BNTX) vs Medline Inc. (MDLN)
A side-by-side comparison of BioNTech SE and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.
BNTX
BioNTech SE
$113.12HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT
MDLN
Medline Inc.
$33.91HealthcareAt close: Aug 19, 2026, 4:00 PM ET
Total return — BNTX vs MDLN
growth of $100 · dividends reinvested · last 1yBNTX +22.6% (+22.6%/yr)MDLN -17.3% (-17.3%/yr)BNTX compounded faster over this window
BNTX MDLN
BNTX vs MDLN: by the numbers
- •MDLN is the larger company ($28.67B vs $28.42B market cap).
- •MDLN is profitable (2.31% net margin) while BNTX runs a net loss (-62.98%).
Metrics side by side
Valuation
| Metric | BNTX | MDLN |
|---|---|---|
| P/E ratio | N/A | 39.43 |
| Forward P/E | N/A | 22.16 |
| P/S ratio | 9.25 | 0.98 |
| P/B ratio | 1.41 | 2.52 |
| EV / EBITDA | N/A | 14.34 |
| FCF yield | 2.16% | 6.94% |
Profitability
| Metric | BNTX | MDLN |
|---|---|---|
| Gross margin | 70.98% | 25.02% |
| Operating margin | -22.63% | 6.07% |
| Net margin | -62.98% | 2.31% |
| ROE | -9.62% | 5.97% |
| ROIC | -10.37% | 4.05% |
Growth (annualized)
| Metric | BNTX | MDLN |
|---|---|---|
| Revenue CAGR (5Y) | 40.61% | N/A |
| Total return CAGR (5Y) | -19.15% | N/A |
Frequently asked
- Is BNTX or MDLN more profitable?
- MDLN runs the higher net margin — BNTX at -62.98% versus MDLN at 2.31%.
Go deeper
Dig into the metrics
Medline P/E ratioBioNTech SE ROEMedline ROEBioNTech SE operating marginMedline operating marginBioNTech SE revenue growthMedline revenue growthBioNTech SE free cash flowMedline free cash flow
BioNTech SE & Medline appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.